Showing results (11-20 of 639) with videos related to
Sort By:
Pageof 64
Bulletin Du Cancer|November 6, 2007
[EGF receptors in colorectal cancers]Jean-Philippe Spano, Stéphane VignotClinical Pharmacology and Therapeutics|February 23, 2024
A Score to Predict the Clinical Usefulness of Therapeutic Drug Monitoring: Application to Oral Molecular Targeted Therapies in CancerArthur Géraud, David Combarel, Christian Funck-Brentano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancerBenjamin Besse, Céline Candé, Jean-Philippe Spano, et al.Cancer|October 19, 2011
Current and emerging targeted therapies for metastatic breast cancerEdith A Perez, Jean-Philippe SpanoCritical Reviews in Oncology/Hematology|February 16, 2015
Patients' satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapyJean-Philippe Spano, David Azria, Anthony GonçalvesBulletin Du Cancer|August 1, 2013
[Small HER2-positive breast cancer: which prognosis and which adjuvant treatment?]Anthony Gonçalves, Maria Vassilakopoulou, Jean-Philippe SpanoBulletin Du Cancer|May 19, 2005
[Aromatase inhibitors in adjuvant setting in breast cancer]Jean-Philippe Spano, David Khayat, Thierry DelozierMedical Oncology (Northwood, London, England)|December 7, 2018
HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH GroupAurelien Gobert, Jean-Philippe Spano, Jacques CadranelBulletin Du Cancer|December 6, 2006
[Update on clinical activity of CCI779 (temsirolimus), mTOR inhibitor]Nicolas Mounier, Stéphane Vignot, Jean-Philippe SpanoCurrent HIV Research|February 19, 2010
Hodgkin lymphoma in HIV positive patientsNicolas Mounier, Michele Spina, Jean Philippe SpanoPageof 64